These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 22864671)
1. Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma. Zha TZ; Hu BS; Yu HF; Tan YF; Zhang Y; Zhang K Tumour Biol; 2012 Dec; 33(6):2125-34. PubMed ID: 22864671 [TBL] [Abstract][Full Text] [Related]
2. Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer. Zhou Y; Zhou N; Fang W; Huo J Diagn Pathol; 2010 Sep; 5():58. PubMed ID: 20846397 [TBL] [Abstract][Full Text] [Related]
3. High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma. Zhang Y; Tan YF; Jiang C; Zhang K; Zha TZ; Zhang M Pathol Oncol Res; 2013 Jan; 19(1):79-88. PubMed ID: 22965687 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells. Zhu M; Li M; Wang T; Linghu E; Wu B Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of Hes-1, a downstream target of notch signaling in hepatocellular carcinoma. Zou JH; Xue TC; Sun C; Li Y; Liu BB; Sun RX; Chen J; Ren ZG; Ye SL Asian Pac J Cancer Prev; 2015; 16(9):3811-6. PubMed ID: 25987042 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma. Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518 [TBL] [Abstract][Full Text] [Related]
7. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity. Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945 [TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of FOXD3 suppresses cell proliferation, invasion and metastasis in hepatocellular carcinoma. He G; Hu S; Zhang D; Wu P; Zhu X; Xin S; Lu G; Ding Y; Liang L Exp Mol Pathol; 2015 Oct; 99(2):374-82. PubMed ID: 26112097 [TBL] [Abstract][Full Text] [Related]
9. The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma. Cui M; Sun J; Hou J; Fang T; Wang X; Ge C; Zhao F; Chen T; Xie H; Cui Y; Yao M; Li J; Li H Tumour Biol; 2016 Oct; 37(10):13521-13531. PubMed ID: 27465557 [TBL] [Abstract][Full Text] [Related]
10. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma. Liu T; Chen J; Xiao S; Lei X Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039 [TBL] [Abstract][Full Text] [Related]
11. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma. Lei X; Li YF; Chen GD; Ou DP; Qiu XX; Zuo CH; Yang LY Oncotarget; 2015 Dec; 6(38):40622-41. PubMed ID: 26536663 [TBL] [Abstract][Full Text] [Related]
12. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F. Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692 [TBL] [Abstract][Full Text] [Related]
13. High expression of proline-rich tyrosine kinase 2 is associated with poor survival of hepatocellular carcinoma via regulating phosphatidylinositol 3-kinase/AKT pathway. Cao J; Chen Y; Fu J; Qian YW; Ren YB; Su B; Luo T; Dai RY; Huang L; Yan JJ; Wu MC; Yan YQ; Wang HY Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S312-23. PubMed ID: 22618716 [TBL] [Abstract][Full Text] [Related]
14. High expression of TRIM44 is associated with enhanced cell proliferation, migration, invasion, and resistance to doxorubicin in hepatocellular carcinoma. Zhu X; Wu Y; Miao X; Li C; Yin H; Yang S; Lu X; Liu Y; Chen Y; Shen R; Chen X; He S Tumour Biol; 2016 Nov; 37(11):14615-14628. PubMed ID: 27619678 [TBL] [Abstract][Full Text] [Related]
15. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. Du R; Wu S; Lv X; Fang H; Wu S; Kang J J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255 [TBL] [Abstract][Full Text] [Related]
17. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma. Wang F; Feng Y; Li P; Wang K; Feng L; Liu YF; Huang H; Guo YB; Mao QS; Xue WJ Oncotarget; 2016 Jan; 7(4):4279-97. PubMed ID: 26701853 [TBL] [Abstract][Full Text] [Related]
18. S100A14 promotes the growth and metastasis of hepatocellular carcinoma. Zhao FT; Jia ZS; Yang Q; Song L; Jiang XJ Asian Pac J Cancer Prev; 2013; 14(6):3831-6. PubMed ID: 23886191 [TBL] [Abstract][Full Text] [Related]
19. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1. Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823 [TBL] [Abstract][Full Text] [Related]
20. IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma. Hu S; Wu X; Zhou B; Xu Z; Qin J; Lu H; Lv L; Gao Y; Deng L; Yin J; Li G J Cancer Res Clin Oncol; 2014 Jun; 140(6):883-93. PubMed ID: 24647926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]